Global Insomnia Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Insomnia Therapy market size was valued at USD 2984 million in 2023 and is forecast to a readjusted size of USD 4192.1 million by 2030 with a CAGR of 5.0% during review period.
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
The Global Info Research report includes an overview of the development of the Insomnia Therapy industry chain, the market status of Hospital Pharmacies (Non-pharmacological Therapy, Pharmacological Therapy), Retail Pharmacies (Non-pharmacological Therapy, Pharmacological Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Insomnia Therapy.
Regionally, the report analyzes the Insomnia Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Insomnia Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Insomnia Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Insomnia Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Non-pharmacological Therapy, Pharmacological Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Insomnia Therapy market.
Regional Analysis: The report involves examining the Insomnia Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Insomnia Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Insomnia Therapy:
Company Analysis: Report covers individual Insomnia Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Insomnia Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Insomnia Therapy. It assesses the current state, advancements, and potential future developments in Insomnia Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Insomnia Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Insomnia Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Insomnia Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Insomnia Therapy, with revenue, gross margin and global market share of Insomnia Therapy from 2019 to 2024.
Chapter 3, the Insomnia Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Insomnia Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Insomnia Therapy.
Chapter 13, to describe Insomnia Therapy research findings and conclusion.
Insomnia is when you aren't sleeping as you should. That can mean you aren't sleeping enough, you aren't sleeping well or you're having trouble falling or staying asleep. For some people, insomnia is a minor inconvenience.
The growth of the global insomnia market size is majorly driven by the increase in prevalence of different types of sleep disorders, such as insomnia and parasomnias, increase in mental depression, and other painful conditions. Mental depression results in difficulty in sleep. For instance, the World Health Organization (WHO) reported that around 280 million population globally suffers from depression. Thus, increase in mental depression across the global population contributes in the insomnia market growth.
The Global Info Research report includes an overview of the development of the Insomnia Therapy industry chain, the market status of Hospital Pharmacies (Non-pharmacological Therapy, Pharmacological Therapy), Retail Pharmacies (Non-pharmacological Therapy, Pharmacological Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Insomnia Therapy.
Regionally, the report analyzes the Insomnia Therapy markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Insomnia Therapy market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Insomnia Therapy market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Insomnia Therapy industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Non-pharmacological Therapy, Pharmacological Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Insomnia Therapy market.
Regional Analysis: The report involves examining the Insomnia Therapy market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Insomnia Therapy market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Insomnia Therapy:
Company Analysis: Report covers individual Insomnia Therapy players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Insomnia Therapy This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to Insomnia Therapy. It assesses the current state, advancements, and potential future developments in Insomnia Therapy areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Insomnia Therapy market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Insomnia Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Non-pharmacological Therapy
- Pharmacological Therapy
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Merck & Co.
- Sanofi
- Pfizer
- Takeda Pharmaceutical Company Ltd.
- Purdue Pharmaceuticals L.P.
- Eisai, Co. Ltd.
- Meda Consumer Healthcare
- Pernix Therapeutics
- Vanda Pharmaceuticals
- ECR Pharmaceuticals
- Fidia Farmaceutici
- Dainippon Sumitomo
- Biocodex
- Eli Lilly and Company
- Ebb Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Insomnia Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Insomnia Therapy, with revenue, gross margin and global market share of Insomnia Therapy from 2019 to 2024.
Chapter 3, the Insomnia Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Insomnia Therapy market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Insomnia Therapy.
Chapter 13, to describe Insomnia Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Insomnia Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Insomnia Therapy by Type
1.3.1 Overview: Global Insomnia Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Insomnia Therapy Consumption Value Market Share by Type in 2023
1.3.3 Non-pharmacological Therapy
1.3.4 Pharmacological Therapy
1.4 Global Insomnia Therapy Market by Application
1.4.1 Overview: Global Insomnia Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Insomnia Therapy Market Size & Forecast
1.6 Global Insomnia Therapy Market Size and Forecast by Region
1.6.1 Global Insomnia Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Insomnia Therapy Market Size by Region, (2019-2030)
1.6.3 North America Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Insomnia Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Insomnia Therapy Product and Solutions
2.1.4 Merck & Co. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co. Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Insomnia Therapy Product and Solutions
2.2.4 Sanofi Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Insomnia Therapy Product and Solutions
2.3.4 Pfizer Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Takeda Pharmaceutical Company Ltd.
2.4.1 Takeda Pharmaceutical Company Ltd. Details
2.4.2 Takeda Pharmaceutical Company Ltd. Major Business
2.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
2.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.5 Purdue Pharmaceuticals L.P.
2.5.1 Purdue Pharmaceuticals L.P. Details
2.5.2 Purdue Pharmaceuticals L.P. Major Business
2.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
2.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
2.6 Eisai, Co. Ltd.
2.6.1 Eisai, Co. Ltd. Details
2.6.2 Eisai, Co. Ltd. Major Business
2.6.3 Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
2.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eisai, Co. Ltd. Recent Developments and Future Plans
2.7 Meda Consumer Healthcare
2.7.1 Meda Consumer Healthcare Details
2.7.2 Meda Consumer Healthcare Major Business
2.7.3 Meda Consumer Healthcare Insomnia Therapy Product and Solutions
2.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Meda Consumer Healthcare Recent Developments and Future Plans
2.8 Pernix Therapeutics
2.8.1 Pernix Therapeutics Details
2.8.2 Pernix Therapeutics Major Business
2.8.3 Pernix Therapeutics Insomnia Therapy Product and Solutions
2.8.4 Pernix Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pernix Therapeutics Recent Developments and Future Plans
2.9 Vanda Pharmaceuticals
2.9.1 Vanda Pharmaceuticals Details
2.9.2 Vanda Pharmaceuticals Major Business
2.9.3 Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
2.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vanda Pharmaceuticals Recent Developments and Future Plans
2.10 ECR Pharmaceuticals
2.10.1 ECR Pharmaceuticals Details
2.10.2 ECR Pharmaceuticals Major Business
2.10.3 ECR Pharmaceuticals Insomnia Therapy Product and Solutions
2.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ECR Pharmaceuticals Recent Developments and Future Plans
2.11 Fidia Farmaceutici
2.11.1 Fidia Farmaceutici Details
2.11.2 Fidia Farmaceutici Major Business
2.11.3 Fidia Farmaceutici Insomnia Therapy Product and Solutions
2.11.4 Fidia Farmaceutici Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Fidia Farmaceutici Recent Developments and Future Plans
2.12 Dainippon Sumitomo
2.12.1 Dainippon Sumitomo Details
2.12.2 Dainippon Sumitomo Major Business
2.12.3 Dainippon Sumitomo Insomnia Therapy Product and Solutions
2.12.4 Dainippon Sumitomo Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Dainippon Sumitomo Recent Developments and Future Plans
2.13 Biocodex
2.13.1 Biocodex Details
2.13.2 Biocodex Major Business
2.13.3 Biocodex Insomnia Therapy Product and Solutions
2.13.4 Biocodex Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Biocodex Recent Developments and Future Plans
2.14 Eli Lilly and Company
2.14.1 Eli Lilly and Company Details
2.14.2 Eli Lilly and Company Major Business
2.14.3 Eli Lilly and Company Insomnia Therapy Product and Solutions
2.14.4 Eli Lilly and Company Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Eli Lilly and Company Recent Developments and Future Plans
2.15 Ebb Therapeutics
2.15.1 Ebb Therapeutics Details
2.15.2 Ebb Therapeutics Major Business
2.15.3 Ebb Therapeutics Insomnia Therapy Product and Solutions
2.15.4 Ebb Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ebb Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Insomnia Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Insomnia Therapy by Company Revenue
3.2.2 Top 3 Insomnia Therapy Players Market Share in 2023
3.2.3 Top 6 Insomnia Therapy Players Market Share in 2023
3.3 Insomnia Therapy Market: Overall Company Footprint Analysis
3.3.1 Insomnia Therapy Market: Region Footprint
3.3.2 Insomnia Therapy Market: Company Product Type Footprint
3.3.3 Insomnia Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Insomnia Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Insomnia Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Insomnia Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Insomnia Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Insomnia Therapy Consumption Value by Type (2019-2030)
6.2 North America Insomnia Therapy Consumption Value by Application (2019-2030)
6.3 North America Insomnia Therapy Market Size by Country
6.3.1 North America Insomnia Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Insomnia Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Insomnia Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Insomnia Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Insomnia Therapy Consumption Value by Type (2019-2030)
7.2 Europe Insomnia Therapy Consumption Value by Application (2019-2030)
7.3 Europe Insomnia Therapy Market Size by Country
7.3.1 Europe Insomnia Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.3 France Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Insomnia Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Insomnia Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Insomnia Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Insomnia Therapy Market Size by Region
8.3.1 Asia-Pacific Insomnia Therapy Consumption Value by Region (2019-2030)
8.3.2 China Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.5 India Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Insomnia Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Insomnia Therapy Consumption Value by Type (2019-2030)
9.2 South America Insomnia Therapy Consumption Value by Application (2019-2030)
9.3 South America Insomnia Therapy Market Size by Country
9.3.1 South America Insomnia Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Insomnia Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Insomnia Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Insomnia Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Insomnia Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Insomnia Therapy Market Size by Country
10.3.1 Middle East & Africa Insomnia Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Insomnia Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Insomnia Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Insomnia Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Insomnia Therapy Market Drivers
11.2 Insomnia Therapy Market Restraints
11.3 Insomnia Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Insomnia Therapy Industry Chain
12.2 Insomnia Therapy Upstream Analysis
12.3 Insomnia Therapy Midstream Analysis
12.4 Insomnia Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Insomnia Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Insomnia Therapy by Type
1.3.1 Overview: Global Insomnia Therapy Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Insomnia Therapy Consumption Value Market Share by Type in 2023
1.3.3 Non-pharmacological Therapy
1.3.4 Pharmacological Therapy
1.4 Global Insomnia Therapy Market by Application
1.4.1 Overview: Global Insomnia Therapy Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global Insomnia Therapy Market Size & Forecast
1.6 Global Insomnia Therapy Market Size and Forecast by Region
1.6.1 Global Insomnia Therapy Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Insomnia Therapy Market Size by Region, (2019-2030)
1.6.3 North America Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.4 Europe Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.6 South America Insomnia Therapy Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Insomnia Therapy Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Insomnia Therapy Product and Solutions
2.1.4 Merck & Co. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co. Recent Developments and Future Plans
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Insomnia Therapy Product and Solutions
2.2.4 Sanofi Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Insomnia Therapy Product and Solutions
2.3.4 Pfizer Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Takeda Pharmaceutical Company Ltd.
2.4.1 Takeda Pharmaceutical Company Ltd. Details
2.4.2 Takeda Pharmaceutical Company Ltd. Major Business
2.4.3 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
2.4.4 Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
2.5 Purdue Pharmaceuticals L.P.
2.5.1 Purdue Pharmaceuticals L.P. Details
2.5.2 Purdue Pharmaceuticals L.P. Major Business
2.5.3 Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
2.5.4 Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
2.6 Eisai, Co. Ltd.
2.6.1 Eisai, Co. Ltd. Details
2.6.2 Eisai, Co. Ltd. Major Business
2.6.3 Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
2.6.4 Eisai, Co. Ltd. Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Eisai, Co. Ltd. Recent Developments and Future Plans
2.7 Meda Consumer Healthcare
2.7.1 Meda Consumer Healthcare Details
2.7.2 Meda Consumer Healthcare Major Business
2.7.3 Meda Consumer Healthcare Insomnia Therapy Product and Solutions
2.7.4 Meda Consumer Healthcare Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Meda Consumer Healthcare Recent Developments and Future Plans
2.8 Pernix Therapeutics
2.8.1 Pernix Therapeutics Details
2.8.2 Pernix Therapeutics Major Business
2.8.3 Pernix Therapeutics Insomnia Therapy Product and Solutions
2.8.4 Pernix Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pernix Therapeutics Recent Developments and Future Plans
2.9 Vanda Pharmaceuticals
2.9.1 Vanda Pharmaceuticals Details
2.9.2 Vanda Pharmaceuticals Major Business
2.9.3 Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
2.9.4 Vanda Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Vanda Pharmaceuticals Recent Developments and Future Plans
2.10 ECR Pharmaceuticals
2.10.1 ECR Pharmaceuticals Details
2.10.2 ECR Pharmaceuticals Major Business
2.10.3 ECR Pharmaceuticals Insomnia Therapy Product and Solutions
2.10.4 ECR Pharmaceuticals Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 ECR Pharmaceuticals Recent Developments and Future Plans
2.11 Fidia Farmaceutici
2.11.1 Fidia Farmaceutici Details
2.11.2 Fidia Farmaceutici Major Business
2.11.3 Fidia Farmaceutici Insomnia Therapy Product and Solutions
2.11.4 Fidia Farmaceutici Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Fidia Farmaceutici Recent Developments and Future Plans
2.12 Dainippon Sumitomo
2.12.1 Dainippon Sumitomo Details
2.12.2 Dainippon Sumitomo Major Business
2.12.3 Dainippon Sumitomo Insomnia Therapy Product and Solutions
2.12.4 Dainippon Sumitomo Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Dainippon Sumitomo Recent Developments and Future Plans
2.13 Biocodex
2.13.1 Biocodex Details
2.13.2 Biocodex Major Business
2.13.3 Biocodex Insomnia Therapy Product and Solutions
2.13.4 Biocodex Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Biocodex Recent Developments and Future Plans
2.14 Eli Lilly and Company
2.14.1 Eli Lilly and Company Details
2.14.2 Eli Lilly and Company Major Business
2.14.3 Eli Lilly and Company Insomnia Therapy Product and Solutions
2.14.4 Eli Lilly and Company Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Eli Lilly and Company Recent Developments and Future Plans
2.15 Ebb Therapeutics
2.15.1 Ebb Therapeutics Details
2.15.2 Ebb Therapeutics Major Business
2.15.3 Ebb Therapeutics Insomnia Therapy Product and Solutions
2.15.4 Ebb Therapeutics Insomnia Therapy Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ebb Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Insomnia Therapy Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Insomnia Therapy by Company Revenue
3.2.2 Top 3 Insomnia Therapy Players Market Share in 2023
3.2.3 Top 6 Insomnia Therapy Players Market Share in 2023
3.3 Insomnia Therapy Market: Overall Company Footprint Analysis
3.3.1 Insomnia Therapy Market: Region Footprint
3.3.2 Insomnia Therapy Market: Company Product Type Footprint
3.3.3 Insomnia Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Insomnia Therapy Consumption Value and Market Share by Type (2019-2024)
4.2 Global Insomnia Therapy Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Insomnia Therapy Consumption Value Market Share by Application (2019-2024)
5.2 Global Insomnia Therapy Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Insomnia Therapy Consumption Value by Type (2019-2030)
6.2 North America Insomnia Therapy Consumption Value by Application (2019-2030)
6.3 North America Insomnia Therapy Market Size by Country
6.3.1 North America Insomnia Therapy Consumption Value by Country (2019-2030)
6.3.2 United States Insomnia Therapy Market Size and Forecast (2019-2030)
6.3.3 Canada Insomnia Therapy Market Size and Forecast (2019-2030)
6.3.4 Mexico Insomnia Therapy Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Insomnia Therapy Consumption Value by Type (2019-2030)
7.2 Europe Insomnia Therapy Consumption Value by Application (2019-2030)
7.3 Europe Insomnia Therapy Market Size by Country
7.3.1 Europe Insomnia Therapy Consumption Value by Country (2019-2030)
7.3.2 Germany Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.3 France Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.5 Russia Insomnia Therapy Market Size and Forecast (2019-2030)
7.3.6 Italy Insomnia Therapy Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Insomnia Therapy Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Insomnia Therapy Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Insomnia Therapy Market Size by Region
8.3.1 Asia-Pacific Insomnia Therapy Consumption Value by Region (2019-2030)
8.3.2 China Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.3 Japan Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.4 South Korea Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.5 India Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Insomnia Therapy Market Size and Forecast (2019-2030)
8.3.7 Australia Insomnia Therapy Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Insomnia Therapy Consumption Value by Type (2019-2030)
9.2 South America Insomnia Therapy Consumption Value by Application (2019-2030)
9.3 South America Insomnia Therapy Market Size by Country
9.3.1 South America Insomnia Therapy Consumption Value by Country (2019-2030)
9.3.2 Brazil Insomnia Therapy Market Size and Forecast (2019-2030)
9.3.3 Argentina Insomnia Therapy Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Insomnia Therapy Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Insomnia Therapy Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Insomnia Therapy Market Size by Country
10.3.1 Middle East & Africa Insomnia Therapy Consumption Value by Country (2019-2030)
10.3.2 Turkey Insomnia Therapy Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Insomnia Therapy Market Size and Forecast (2019-2030)
10.3.4 UAE Insomnia Therapy Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Insomnia Therapy Market Drivers
11.2 Insomnia Therapy Market Restraints
11.3 Insomnia Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Insomnia Therapy Industry Chain
12.2 Insomnia Therapy Upstream Analysis
12.3 Insomnia Therapy Midstream Analysis
12.4 Insomnia Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Insomnia Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Insomnia Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Insomnia Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck & Co. Company Information, Head Office, and Major Competitors
Table 6. Merck & Co. Major Business
Table 7. Merck & Co. Insomnia Therapy Product and Solutions
Table 8. Merck & Co. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck & Co. Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Insomnia Therapy Product and Solutions
Table 13. Sanofi Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Insomnia Therapy Product and Solutions
Table 18. Pfizer Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Takeda Pharmaceutical Company Ltd. Company Information, Head Office, and Major Competitors
Table 21. Takeda Pharmaceutical Company Ltd. Major Business
Table 22. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
Table 23. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Table 25. Purdue Pharmaceuticals L.P. Company Information, Head Office, and Major Competitors
Table 26. Purdue Pharmaceuticals L.P. Major Business
Table 27. Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
Table 28. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
Table 30. Eisai, Co. Ltd. Company Information, Head Office, and Major Competitors
Table 31. Eisai, Co. Ltd. Major Business
Table 32. Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
Table 33. Eisai, Co. Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Eisai, Co. Ltd. Recent Developments and Future Plans
Table 35. Meda Consumer Healthcare Company Information, Head Office, and Major Competitors
Table 36. Meda Consumer Healthcare Major Business
Table 37. Meda Consumer Healthcare Insomnia Therapy Product and Solutions
Table 38. Meda Consumer Healthcare Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Meda Consumer Healthcare Recent Developments and Future Plans
Table 40. Pernix Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Pernix Therapeutics Major Business
Table 42. Pernix Therapeutics Insomnia Therapy Product and Solutions
Table 43. Pernix Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pernix Therapeutics Recent Developments and Future Plans
Table 45. Vanda Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Vanda Pharmaceuticals Major Business
Table 47. Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
Table 48. Vanda Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Vanda Pharmaceuticals Recent Developments and Future Plans
Table 50. ECR Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. ECR Pharmaceuticals Major Business
Table 52. ECR Pharmaceuticals Insomnia Therapy Product and Solutions
Table 53. ECR Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. ECR Pharmaceuticals Recent Developments and Future Plans
Table 55. Fidia Farmaceutici Company Information, Head Office, and Major Competitors
Table 56. Fidia Farmaceutici Major Business
Table 57. Fidia Farmaceutici Insomnia Therapy Product and Solutions
Table 58. Fidia Farmaceutici Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Fidia Farmaceutici Recent Developments and Future Plans
Table 60. Dainippon Sumitomo Company Information, Head Office, and Major Competitors
Table 61. Dainippon Sumitomo Major Business
Table 62. Dainippon Sumitomo Insomnia Therapy Product and Solutions
Table 63. Dainippon Sumitomo Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Dainippon Sumitomo Recent Developments and Future Plans
Table 65. Biocodex Company Information, Head Office, and Major Competitors
Table 66. Biocodex Major Business
Table 67. Biocodex Insomnia Therapy Product and Solutions
Table 68. Biocodex Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Biocodex Recent Developments and Future Plans
Table 70. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 71. Eli Lilly and Company Major Business
Table 72. Eli Lilly and Company Insomnia Therapy Product and Solutions
Table 73. Eli Lilly and Company Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly and Company Recent Developments and Future Plans
Table 75. Ebb Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Ebb Therapeutics Major Business
Table 77. Ebb Therapeutics Insomnia Therapy Product and Solutions
Table 78. Ebb Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Ebb Therapeutics Recent Developments and Future Plans
Table 80. Global Insomnia Therapy Revenue (USD Million) by Players (2019-2024)
Table 81. Global Insomnia Therapy Revenue Share by Players (2019-2024)
Table 82. Breakdown of Insomnia Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Insomnia Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Insomnia Therapy Players
Table 85. Insomnia Therapy Market: Company Product Type Footprint
Table 86. Insomnia Therapy Market: Company Product Application Footprint
Table 87. Insomnia Therapy New Market Entrants and Barriers to Market Entry
Table 88. Insomnia Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Insomnia Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Insomnia Therapy Consumption Value Share by Type (2019-2024)
Table 91. Global Insomnia Therapy Consumption Value Forecast by Type (2025-2030)
Table 92. Global Insomnia Therapy Consumption Value by Application (2019-2024)
Table 93. Global Insomnia Therapy Consumption Value Forecast by Application (2025-2030)
Table 94. North America Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Insomnia Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Insomnia Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Insomnia Therapy Raw Material
Table 125. Key Suppliers of Insomnia Therapy Raw Materials
Table 1. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Insomnia Therapy Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Insomnia Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Insomnia Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck & Co. Company Information, Head Office, and Major Competitors
Table 6. Merck & Co. Major Business
Table 7. Merck & Co. Insomnia Therapy Product and Solutions
Table 8. Merck & Co. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck & Co. Recent Developments and Future Plans
Table 10. Sanofi Company Information, Head Office, and Major Competitors
Table 11. Sanofi Major Business
Table 12. Sanofi Insomnia Therapy Product and Solutions
Table 13. Sanofi Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi Recent Developments and Future Plans
Table 15. Pfizer Company Information, Head Office, and Major Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Insomnia Therapy Product and Solutions
Table 18. Pfizer Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Pfizer Recent Developments and Future Plans
Table 20. Takeda Pharmaceutical Company Ltd. Company Information, Head Office, and Major Competitors
Table 21. Takeda Pharmaceutical Company Ltd. Major Business
Table 22. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Product and Solutions
Table 23. Takeda Pharmaceutical Company Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Takeda Pharmaceutical Company Ltd. Recent Developments and Future Plans
Table 25. Purdue Pharmaceuticals L.P. Company Information, Head Office, and Major Competitors
Table 26. Purdue Pharmaceuticals L.P. Major Business
Table 27. Purdue Pharmaceuticals L.P. Insomnia Therapy Product and Solutions
Table 28. Purdue Pharmaceuticals L.P. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Purdue Pharmaceuticals L.P. Recent Developments and Future Plans
Table 30. Eisai, Co. Ltd. Company Information, Head Office, and Major Competitors
Table 31. Eisai, Co. Ltd. Major Business
Table 32. Eisai, Co. Ltd. Insomnia Therapy Product and Solutions
Table 33. Eisai, Co. Ltd. Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Eisai, Co. Ltd. Recent Developments and Future Plans
Table 35. Meda Consumer Healthcare Company Information, Head Office, and Major Competitors
Table 36. Meda Consumer Healthcare Major Business
Table 37. Meda Consumer Healthcare Insomnia Therapy Product and Solutions
Table 38. Meda Consumer Healthcare Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Meda Consumer Healthcare Recent Developments and Future Plans
Table 40. Pernix Therapeutics Company Information, Head Office, and Major Competitors
Table 41. Pernix Therapeutics Major Business
Table 42. Pernix Therapeutics Insomnia Therapy Product and Solutions
Table 43. Pernix Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pernix Therapeutics Recent Developments and Future Plans
Table 45. Vanda Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Vanda Pharmaceuticals Major Business
Table 47. Vanda Pharmaceuticals Insomnia Therapy Product and Solutions
Table 48. Vanda Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Vanda Pharmaceuticals Recent Developments and Future Plans
Table 50. ECR Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. ECR Pharmaceuticals Major Business
Table 52. ECR Pharmaceuticals Insomnia Therapy Product and Solutions
Table 53. ECR Pharmaceuticals Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. ECR Pharmaceuticals Recent Developments and Future Plans
Table 55. Fidia Farmaceutici Company Information, Head Office, and Major Competitors
Table 56. Fidia Farmaceutici Major Business
Table 57. Fidia Farmaceutici Insomnia Therapy Product and Solutions
Table 58. Fidia Farmaceutici Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Fidia Farmaceutici Recent Developments and Future Plans
Table 60. Dainippon Sumitomo Company Information, Head Office, and Major Competitors
Table 61. Dainippon Sumitomo Major Business
Table 62. Dainippon Sumitomo Insomnia Therapy Product and Solutions
Table 63. Dainippon Sumitomo Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Dainippon Sumitomo Recent Developments and Future Plans
Table 65. Biocodex Company Information, Head Office, and Major Competitors
Table 66. Biocodex Major Business
Table 67. Biocodex Insomnia Therapy Product and Solutions
Table 68. Biocodex Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Biocodex Recent Developments and Future Plans
Table 70. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 71. Eli Lilly and Company Major Business
Table 72. Eli Lilly and Company Insomnia Therapy Product and Solutions
Table 73. Eli Lilly and Company Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Eli Lilly and Company Recent Developments and Future Plans
Table 75. Ebb Therapeutics Company Information, Head Office, and Major Competitors
Table 76. Ebb Therapeutics Major Business
Table 77. Ebb Therapeutics Insomnia Therapy Product and Solutions
Table 78. Ebb Therapeutics Insomnia Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Ebb Therapeutics Recent Developments and Future Plans
Table 80. Global Insomnia Therapy Revenue (USD Million) by Players (2019-2024)
Table 81. Global Insomnia Therapy Revenue Share by Players (2019-2024)
Table 82. Breakdown of Insomnia Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Insomnia Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 84. Head Office of Key Insomnia Therapy Players
Table 85. Insomnia Therapy Market: Company Product Type Footprint
Table 86. Insomnia Therapy Market: Company Product Application Footprint
Table 87. Insomnia Therapy New Market Entrants and Barriers to Market Entry
Table 88. Insomnia Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Insomnia Therapy Consumption Value (USD Million) by Type (2019-2024)
Table 90. Global Insomnia Therapy Consumption Value Share by Type (2019-2024)
Table 91. Global Insomnia Therapy Consumption Value Forecast by Type (2025-2030)
Table 92. Global Insomnia Therapy Consumption Value by Application (2019-2024)
Table 93. Global Insomnia Therapy Consumption Value Forecast by Application (2025-2030)
Table 94. North America Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 95. North America Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 96. North America Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 97. North America Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 98. North America Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 99. North America Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 100. Europe Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 101. Europe Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 102. Europe Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 103. Europe Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 104. Europe Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 107. Asia-Pacific Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 108. Asia-Pacific Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 109. Asia-Pacific Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 110. Asia-Pacific Insomnia Therapy Consumption Value by Region (2019-2024) & (USD Million)
Table 111. Asia-Pacific Insomnia Therapy Consumption Value by Region (2025-2030) & (USD Million)
Table 112. South America Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 113. South America Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 114. South America Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 115. South America Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 116. South America Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 117. South America Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 118. Middle East & Africa Insomnia Therapy Consumption Value by Type (2019-2024) & (USD Million)
Table 119. Middle East & Africa Insomnia Therapy Consumption Value by Type (2025-2030) & (USD Million)
Table 120. Middle East & Africa Insomnia Therapy Consumption Value by Application (2019-2024) & (USD Million)
Table 121. Middle East & Africa Insomnia Therapy Consumption Value by Application (2025-2030) & (USD Million)
Table 122. Middle East & Africa Insomnia Therapy Consumption Value by Country (2019-2024) & (USD Million)
Table 123. Middle East & Africa Insomnia Therapy Consumption Value by Country (2025-2030) & (USD Million)
Table 124. Insomnia Therapy Raw Material
Table 125. Key Suppliers of Insomnia Therapy Raw Materials
LIST OF FIGURES
Figure 1. Insomnia Therapy Picture
Figure 2. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Insomnia Therapy Consumption Value Market Share by Type in 2023
Figure 4. Non-pharmacological Therapy
Figure 5. Pharmacological Therapy
Figure 6. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Insomnia Therapy Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Insomnia Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Insomnia Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Insomnia Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Insomnia Therapy Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Insomnia Therapy Consumption Value Market Share by Region in 2023
Figure 16. North America Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Insomnia Therapy Revenue Share by Players in 2023
Figure 22. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Insomnia Therapy Market Share in 2023
Figure 24. Global Top 6 Players Insomnia Therapy Market Share in 2023
Figure 25. Global Insomnia Therapy Consumption Value Share by Type (2019-2024)
Figure 26. Global Insomnia Therapy Market Share Forecast by Type (2025-2030)
Figure 27. Global Insomnia Therapy Consumption Value Share by Application (2019-2024)
Figure 28. Global Insomnia Therapy Market Share Forecast by Application (2025-2030)
Figure 29. North America Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. France Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Region (2019-2030)
Figure 46. China Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. India Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Insomnia Therapy Market Drivers
Figure 64. Insomnia Therapy Market Restraints
Figure 65. Insomnia Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Insomnia Therapy in 2023
Figure 68. Manufacturing Process Analysis of Insomnia Therapy
Figure 69. Insomnia Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Insomnia Therapy Picture
Figure 2. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Insomnia Therapy Consumption Value Market Share by Type in 2023
Figure 4. Non-pharmacological Therapy
Figure 5. Pharmacological Therapy
Figure 6. Global Insomnia Therapy Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Insomnia Therapy Consumption Value Market Share by Application in 2023
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Insomnia Therapy Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Insomnia Therapy Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Insomnia Therapy Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Insomnia Therapy Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Insomnia Therapy Consumption Value Market Share by Region in 2023
Figure 16. North America Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Insomnia Therapy Revenue Share by Players in 2023
Figure 22. Insomnia Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Insomnia Therapy Market Share in 2023
Figure 24. Global Top 6 Players Insomnia Therapy Market Share in 2023
Figure 25. Global Insomnia Therapy Consumption Value Share by Type (2019-2024)
Figure 26. Global Insomnia Therapy Market Share Forecast by Type (2025-2030)
Figure 27. Global Insomnia Therapy Consumption Value Share by Application (2019-2024)
Figure 28. Global Insomnia Therapy Market Share Forecast by Application (2025-2030)
Figure 29. North America Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 39. France Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Insomnia Therapy Consumption Value Market Share by Region (2019-2030)
Figure 46. China Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 49. India Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Insomnia Therapy Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Insomnia Therapy Consumption Value (2019-2030) & (USD Million)
Figure 63. Insomnia Therapy Market Drivers
Figure 64. Insomnia Therapy Market Restraints
Figure 65. Insomnia Therapy Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Insomnia Therapy in 2023
Figure 68. Manufacturing Process Analysis of Insomnia Therapy
Figure 69. Insomnia Therapy Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
